GENETICS & OMICS
Dr Laura Fachal (Wellcome Sanger Institute, UK) has played a pivotal role in supporting this section
Filter
-
2023 LHFPL3-AS2 lncRNA in CD
Reduced *LHFPL3-AS2* lncRNA expression is linked to altered epithelial polarity and proliferation, and to ileal ulceration in Crohn disease -
2023 IBD within and across families
Risk Factors for Developing Inflammatory Bowel Disease Within and Across Families with a Family History of IBD -
2023 HLA-DRB1*01:03 and Severe Ulcerative Colitis
-
2023 Genetic architecture of IBD across East Asia & Europe
Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries -
2023 Epigenetic Analysis of the Trial of Prevention of Post-operative CD
Genome-Wide Methylation Profiling in 229 Patients With Crohn’s Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn’s Disease (TOPPIC) -
2023 EGR2, ICAM1, IL33, INPP5D, ITK, PDGFD, RGS1, TLR4 in IBD Ashkenazi Jewish
Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients -
2022 REVIEW Multiomics
-
2022 multiple genes & rare variants associated to CD susceptibility
Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility -
2021 Three new susceptibility loci identified in Koreans with IBD
Identification of Three Novel Susceptibility Loci for Inflammatory Bowel Disease in Koreans in an Extended Genome-Wide Association Study -
2020 Genetic Analysis of UC in Japanese Individuals
Genetic Analysis of Ulcerative Colitis in Japanese Individuals Using Population-specific SNP Array